Cargando…

Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study

AIM: Norfloxacin (NFX) has low ocular bioavailability. The current work aimed to develop NFX-loaded nanoparticle (NP)-laden hydrogels to improve the ocular potential of NFX, minimize the need for frequent instillations and lower undesirable side effects. METHODS: NFX-loaded NPs were developed via th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebreel, Rana M, Edris, Noha A, Elmofty, Hala M, Tadros, Mina I, El-Nabarawi, Mohamed A, Hassan, Doaa H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875077/
https://www.ncbi.nlm.nih.gov/pubmed/33584095
http://dx.doi.org/10.2147/DDDT.S293127
_version_ 1783649719244816384
author Gebreel, Rana M
Edris, Noha A
Elmofty, Hala M
Tadros, Mina I
El-Nabarawi, Mohamed A
Hassan, Doaa H
author_facet Gebreel, Rana M
Edris, Noha A
Elmofty, Hala M
Tadros, Mina I
El-Nabarawi, Mohamed A
Hassan, Doaa H
author_sort Gebreel, Rana M
collection PubMed
description AIM: Norfloxacin (NFX) has low ocular bioavailability. The current work aimed to develop NFX-loaded nanoparticle (NP)-laden hydrogels to improve the ocular potential of NFX, minimize the need for frequent instillations and lower undesirable side effects. METHODS: NFX-loaded NPs were developed via the double-emulsion/solvent evaporation technique, according to 2(1).4(1) full factorial design, using two types of polylactic-co-glycolic acid (PLGA) polymer and four (drug: polymer) ratios. NPs were evaluated for particle size (PS), polydispersity index (PDI), zeta potential (ZP), drug entrapment efficiency percentage (EE%), drug percentage released after 30 min (Q(30min)) and 12 hours (Q(12h)), drug percentage permeated through goat corneas after 30 min (P(30min)) and 12 hours (P(12h)) and morphology. Two formulae were statistically selected and incorporated into hydroxypropyl methylcellulose (HPMC)-based hydrogels; G1 – G4. The latter systems were evaluated for appearance, clarity, pH, spreadability, rheology, drug percentages released, drug percentages permeated, antimicrobial activity against Pseudomonas aeruginosa, and histopathological changes. RESULTS: The selected NPs (NP2 and NP6) were spherical in shape and possessed suitable PS (392.02 nm and 190.51 nm) and PDI (0.17 and 0.18), high magnitude of ZP (−30.43 mV and −33.62 mV), high EE% (79.24% and 91.72%), low Q(30min) (10.96% and 16.65%) and P(30min) (17.39% and 21.05%) and promising Q(12h) (58.23% and 71.20%) and P(12h) (53.31% and 65.01%), respectively. Clear, spreadable, tolerable, pseudoplastic, and thixotropic HPMC-based hydrogels were developed. They showed more prolonged drug release and drug permeation profiles. NP2- and NP6-laden hydrogels (G3 and G4 systems, respectively) had promising antibacterial activity, and reasonable histopathological safety. CONCLUSION: G3 and G4 are potential ocular delivery systems for NFX.
format Online
Article
Text
id pubmed-7875077
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78750772021-02-11 Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study Gebreel, Rana M Edris, Noha A Elmofty, Hala M Tadros, Mina I El-Nabarawi, Mohamed A Hassan, Doaa H Drug Des Devel Ther Original Research AIM: Norfloxacin (NFX) has low ocular bioavailability. The current work aimed to develop NFX-loaded nanoparticle (NP)-laden hydrogels to improve the ocular potential of NFX, minimize the need for frequent instillations and lower undesirable side effects. METHODS: NFX-loaded NPs were developed via the double-emulsion/solvent evaporation technique, according to 2(1).4(1) full factorial design, using two types of polylactic-co-glycolic acid (PLGA) polymer and four (drug: polymer) ratios. NPs were evaluated for particle size (PS), polydispersity index (PDI), zeta potential (ZP), drug entrapment efficiency percentage (EE%), drug percentage released after 30 min (Q(30min)) and 12 hours (Q(12h)), drug percentage permeated through goat corneas after 30 min (P(30min)) and 12 hours (P(12h)) and morphology. Two formulae were statistically selected and incorporated into hydroxypropyl methylcellulose (HPMC)-based hydrogels; G1 – G4. The latter systems were evaluated for appearance, clarity, pH, spreadability, rheology, drug percentages released, drug percentages permeated, antimicrobial activity against Pseudomonas aeruginosa, and histopathological changes. RESULTS: The selected NPs (NP2 and NP6) were spherical in shape and possessed suitable PS (392.02 nm and 190.51 nm) and PDI (0.17 and 0.18), high magnitude of ZP (−30.43 mV and −33.62 mV), high EE% (79.24% and 91.72%), low Q(30min) (10.96% and 16.65%) and P(30min) (17.39% and 21.05%) and promising Q(12h) (58.23% and 71.20%) and P(12h) (53.31% and 65.01%), respectively. Clear, spreadable, tolerable, pseudoplastic, and thixotropic HPMC-based hydrogels were developed. They showed more prolonged drug release and drug permeation profiles. NP2- and NP6-laden hydrogels (G3 and G4 systems, respectively) had promising antibacterial activity, and reasonable histopathological safety. CONCLUSION: G3 and G4 are potential ocular delivery systems for NFX. Dove 2021-02-05 /pmc/articles/PMC7875077/ /pubmed/33584095 http://dx.doi.org/10.2147/DDDT.S293127 Text en © 2021 Gebreel et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gebreel, Rana M
Edris, Noha A
Elmofty, Hala M
Tadros, Mina I
El-Nabarawi, Mohamed A
Hassan, Doaa H
Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study
title Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study
title_full Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study
title_fullStr Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study
title_full_unstemmed Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study
title_short Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study
title_sort development and characterization of plga nanoparticle-laden hydrogels for sustained ocular delivery of norfloxacin in the treatment of pseudomonas keratitis: an experimental study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875077/
https://www.ncbi.nlm.nih.gov/pubmed/33584095
http://dx.doi.org/10.2147/DDDT.S293127
work_keys_str_mv AT gebreelranam developmentandcharacterizationofplgananoparticleladenhydrogelsforsustainedoculardeliveryofnorfloxacininthetreatmentofpseudomonaskeratitisanexperimentalstudy
AT edrisnohaa developmentandcharacterizationofplgananoparticleladenhydrogelsforsustainedoculardeliveryofnorfloxacininthetreatmentofpseudomonaskeratitisanexperimentalstudy
AT elmoftyhalam developmentandcharacterizationofplgananoparticleladenhydrogelsforsustainedoculardeliveryofnorfloxacininthetreatmentofpseudomonaskeratitisanexperimentalstudy
AT tadrosminai developmentandcharacterizationofplgananoparticleladenhydrogelsforsustainedoculardeliveryofnorfloxacininthetreatmentofpseudomonaskeratitisanexperimentalstudy
AT elnabarawimohameda developmentandcharacterizationofplgananoparticleladenhydrogelsforsustainedoculardeliveryofnorfloxacininthetreatmentofpseudomonaskeratitisanexperimentalstudy
AT hassandoaah developmentandcharacterizationofplgananoparticleladenhydrogelsforsustainedoculardeliveryofnorfloxacininthetreatmentofpseudomonaskeratitisanexperimentalstudy